tiprankstipranks
Aurora Cannabis reports Q1 revenue C$49.3M, consensus C$52.5M
The Fly

Aurora Cannabis reports Q1 revenue C$49.3M, consensus C$52.5M

Reports Q1 loss (C$51.9M). The company said, "We are quickly approaching our positive Adjusted EBITDA goal and are on track to achieve up to $170 million in annualized cost savings by December 31, 2022, having already realized $140 million through Q1 2023. Our strengthened balance sheet and strong cash position has facilitated early repurchases of convertible debt of approximately US$160 million in 2022. Through profitable growth opportunities, particularly in our high-margin global medical cannabis business where we remain the #1 Canadian LP in revenues, disciplined capital deployment, and the completion of our cost structure rationalization, we are well-positioned to enhance the long-term value of our differentiated global cannabis company."

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on ACB:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles